WeVote
Log In

Bill

Bill

HD 4243

An Act establishing a task force to study equitable access to psilocybin and other entheogenic plants

194th Legislature (2025-2026) Introduced by Mike Connolly

Massachusetts task force to study equitable access to psilocybin and psychoactive plants, examining barriers and recommending regulatory frameworks.

0
WeVote Research Nonpartisan
Bill Summary · HD 4243

Legislative bill overview

HD 4243 establishes a task force to investigate equitable access to psilocybin and other entheogenic plants (psychoactive plants used in spiritual/therapeutic contexts) in Massachusetts. The task force would examine barriers to access, potential therapeutic applications, and recommend policies for equitable distribution and regulation of these substances.

Why this is important

This reflects growing research into psilocybin's potential therapeutic benefits for conditions like depression, PTSD, and end-of-life anxiety, with several states and cities moving toward decriminalization or clinical frameworks. The "equitable access" focus addresses concerns that emerging psychedelic therapies could become available only to wealthy populations, creating new health disparities.

Potential points of contention

  • Federal legal status: Psilocybin remains a Schedule I controlled substance federally, creating tension between state study recommendations and federal law enforcement priorities
  • Scope ambiguity: "Other entheogenic plants" is broad and undefined, potentially encompassing substances beyond psilocybin with varying safety profiles and research bases
  • Implementation feasibility: A study task force doesn't resolve the fundamental legal barrier—recommendations may be politically difficult to act upon without federal policy changes

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.